Myocardial perfusion imaging using adenosine receptor agonists

Details for Australian Patent Application No. 2004316372 (hide)

Owner Gilead Palo Alto, Inc.

Inventors Belardinelli, Luiz; Rosner, Mitchell

Agent Freehills

Pub. Number AU-B-2004316372

PCT Pub. Number WO2005/082379

Filing date 27 January 2004

Wipo publication date 9 September 2005

Acceptance publication date 12 May 2011

International Classifications

A61K 31/7076 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082379 Priority application(s): WO2005/082379

15 October 2009 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc. 2005

12 May 2011 Application Accepted

  Published as AU-B-2004316372

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004316373-Multiple pricing shared single jackpot in a lottery

2004316371-A system and method of providing a guarantee in a lottery